Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Neoplasms
×
etoposide phosphate
×
Clear all
Filters
3
NCT02964013
2025-10-14
KEYVIBE-001
Merck Sharp & Dohme LLC
Phase 1
Completed
474 enrolled
39 charts